Venus Remedies is aiming to achieve a top-line of Rs 1000 crore by FY18 following several new drug launches and increased marketing efforts. The company registered a turnover of Rs 525 crore in FY14. The company has invested around Rs 500 crore in R&D over the last 10 years and received 100 plus patents, 70 trademarks, 9 copyrights and 120 research publications in peer reviewed journals for its R&D based products across the globe. Further, the company has 25 innovative products in pipeline and commercialised 15 products in domestic and international markets.
Following the GMP certification by European and other regulated markets for its manufacturing plants, the company has been able to make international tie-ups for its research products with some of the best pharmaceutical companies of the world.
Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.
